test

Troy Wuertz

Ikarian Capital, Llc

Assets Managed
$1.232B
Holdings
139
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-3.84%(2Q avg: 12.75%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ikarian Capital, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 139 positions.

Assets under management

The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.232B in assets, with a quarterly growth rate of -3.84% and a 2-quarter average growth rate of 12.75%. The portfolio is managed by Troy Wuertz, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
TERN
Terns Pharmaceuticals Inc
Recent Activity
Increased 66.41%
11.38%
$140.044M
2.656M shares@ $52.72 avg price
XBI
Spdr S&p Biotech Etf
Recent Activity
Decreased -5.88%
8.3%
$102.184M Put
800,000 shares@ $127.73 avg price
CYTK
Cytokinetics Inc
Recent Activity
Increased 168.03%
6.65%
$81.891M
1.242M shares@ $65.92 avg price
QQQ
Invesco Qqq Trust Series 1
Recent Activity
New Position
4.69%
$57.718M Put
100,000 shares@ $577.18 avg price
KOD
Kodiak Sciences Inc
Recent Activity
Increased 89.75%
4.23%
$52.064M
1.366M shares@ $38.13 avg price
IWM
Ishares Russell 2000 Etf
Recent Activity
New Position
4.03%
$49.6M Put
200,000 shares@ $248.0 avg price
ABVX
Abivax Sa-adr
Recent Activity
Increased 6%
3.16%
$38.892M
350,935 shares@ $110.83 avg price
ALMS
Alumis Inc
Recent Activity
Increased 600.22%
2.65%
$32.564M
1.478M shares@ $22.03 avg price
BMY
Bristol-myers Squibb Co
Recent Activity
New Position
2.47%
$30.325M Put
500,000 shares@ $60.65 avg price
CAPR
Capricor Therapeutics Inc
Recent Activity
Increased 51.91%
2.17%
$26.692M
878,015 shares@ $30.4 avg price

1-10 of 139